featured
Association of SGLT2 Inhibitor Use With Risk of Incident Dementia and All-Cause Mortality in Older Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks
Diabetes Obes Metab 2024 Sep 09;[EPub Ahead of Print], YW Pai, IC Chen, JF Lin, XH Chen, HH Chen, MH Chang, JA Huang, CH LinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.